Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Arch Ital Biol ; 147(1-2): 1-10, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19678592

ABSTRACT

"Attentional" adaptations are fundamental effects for sport performance. We tested the hypothesis that tiredness and muscular fatigue poorly affect visuo-spatial attentional processes in elite karate athletes. To this aim, 14 elite karate athletes and 11 non-athletes were involved in an isometric contraction exercise protocol up to muscular fatigue. Blood lactate and attention measurements were taken. Posner's test probed "endogenous" (i.e., internally planned allocation of spatial attention) and "reflexive" (i.e., brisk variation of endogenous spatial attention due to unexpected external stimuli) attention. Lactate and attentional measurements were performed before (Block 1, B1) and after the fatiguing exercise (B2) and at the end of a recovery period (B3). Compared to the non-athletes, the athletes showed a better performance in the fatigue protocol, confirmed by the higher absolute lactate values in B2. The correct responses in the "valid trials" probing "endogenous" attention were 92.4% (B1), 93.9% (B2), and 95.8% (B3) in the non-athletes, and 98.5%, 96.4%, 95.5% in the elite karate athletes. The correct responses in the "invalid trials" probing "reflexive" attention were 95.4%, 89.7%, 93.2% in the non-athletes, and 96.4%, 97.3%, 98.5% in the elite karate athletes. The percentage of correct responses in the "invalid" trials significantly decreased from B1 to B2 in the non-athletes but not in the elite karate athletes. In conclusion, tiredness and muscular fatigue do not affect "reflexive" attentional processes of elite karate athletes, which is crucial to contrast attacks coming from an unexpected spatial region.


Subject(s)
Attention/physiology , Fatigue/physiopathology , Martial Arts/physiology , Space Perception/physiology , Sports , Acoustic Stimulation/methods , Analysis of Variance , Female , Humans , Male , Neuropsychological Tests , Reaction Time/physiology , Young Adult
2.
J Neuroimmunol ; 129(1-2): 66-73, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12161022

ABSTRACT

Experiments were conducted in both HEK cells and cerebellar neurons to investigate whether CXC chemokine receptor 2 (CXCR2) is functionally coupled to GluR1. The co-expression of CXCR2 with GluR1 in HEK cells increased (i) the GluR1 "apparent" affinity for the transmitter; (ii) the GluR1 channel open probability; and (iii) GluR1 binding site cooperativity upon CXCR2 stimulation with CXC chemokine ligand 2 (CXCL2). The affinity of C-terminal-deleted GluR1 for glutamate (Glu) remained stable instead. Furthermore, CXCL2 increased the binding site cooperativity of AMPA receptors in rat cerebellar granule cells; and the amplitude of spontaneous excitatory postsynaptic current (sEPSCs) in Purkinje neurons (PNs). Our findings indicate that the coupling of CXCR2 with GluR1 may modulate glutamatergic synaptic transmission.


Subject(s)
Central Nervous System/metabolism , Chemokines, CXC/metabolism , Glutamic Acid/metabolism , Receptors, AMPA/metabolism , Receptors, Interleukin-8B/metabolism , Synapses/metabolism , Synaptic Transmission/immunology , Animals , Binding Sites/drug effects , Binding Sites/immunology , Cells, Cultured , Central Nervous System/immunology , Cerebellar Cortex/drug effects , Cerebellar Cortex/immunology , Cerebellar Cortex/metabolism , Chemokines, CXC/immunology , Chemokines, CXC/pharmacology , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/immunology , Gene Expression Regulation/drug effects , Gene Expression Regulation/immunology , Glutamic Acid/pharmacology , Humans , Ion Channels/genetics , Ion Channels/immunology , Neurons/drug effects , Neurons/immunology , Neurons/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Receptors, AMPA/genetics , Receptors, AMPA/immunology , Receptors, Interleukin-8B/genetics , Receptors, Interleukin-8B/immunology , Synapses/immunology
3.
Proc Natl Acad Sci U S A ; 97(11): 6197-201, 2000 May 23.
Article in English | MEDLINE | ID: mdl-10811878

ABSTRACT

Cultured cerebellar granule neurons are widely used as a cellular model to study mechanisms of neuronal cell death because they undergo programmed cell death when switched from a culture medium containing 25 mM to one containing 5 mM K(+). We have found that the growth-related gene product beta (GRObeta) partially prevents the K(+)-depletion-induced cell death, and that the neuroprotective action of GRObeta on granule cells is mediated through the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) type of ionotropic glutamate receptors. GRObeta-induced survival was suppressed by 6-cyano-7-nitroquinoxaline-2,3-dione, which is a specific antagonist of AMPA/kainate receptors; it was not affected by the inhibitor of N-methyl-D-aspartate receptors, 2-amino-5-phosphonopentanoic acid, and was comparable to the survival of granule cells induced by AMPA (10 microM) treatment. Moreover, GRObeta-induced neuroprotection was abolished when granule cells were treated with antisense oligonucleotides specific for the AMPA receptor subunits, which significantly reduced receptor expression, as verified by Western blot analysis with subunit-specific antibodies and by granule cell electrophysiological sensitivity to AMPA. Our data demonstrate that GRObeta is neurotrophic for cerebellar granule cells, and that this activity depends on AMPA receptors.


Subject(s)
Apoptosis/drug effects , Benzodiazepines , Cerebellar Cortex/drug effects , Chemokines, CXC , Chemotactic Factors/pharmacology , Growth Substances/pharmacology , Intercellular Signaling Peptides and Proteins , Nerve Tissue Proteins/physiology , Neuroprotective Agents/pharmacology , Receptors, AMPA/physiology , 2-Amino-5-phosphonovalerate/pharmacology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Anti-Anxiety Agents/pharmacology , Cerebellar Cortex/cytology , DNA, Complementary/genetics , Gene Expression Regulation/drug effects , Interleukin-8/pharmacology , Ion Channel Gating , Nerve Tissue Proteins/drug effects , Nerve Tissue Proteins/genetics , Oligodeoxyribonucleotides, Antisense/pharmacology , Potassium/pharmacology , Potassium/physiology , Rats , Rats, Wistar , Receptors, AMPA/drug effects , Receptors, AMPA/genetics , Receptors, N-Methyl-D-Aspartate/drug effects
4.
Proc Natl Acad Sci U S A ; 95(17): 10246-50, 1998 Aug 18.
Article in English | MEDLINE | ID: mdl-9707632

ABSTRACT

Zn2+ is a key structural/functional component of many proteins and is present at high concentrations in the brain and retina, where it modulates ligand-gated receptors. Therefore, a study was made of the effects of zinc on homomeric neuronal nicotinic receptors expressed in Xenopus oocytes after injection of cDNAs encoding the chicken wild or mutant alpha7 subunits. In oocytes expressing wild-type receptors, Zn2+ alone did not elicit appreciable membrane currents. Acetylcholine (AcCho) elicited large currents (IAcCho) that were reduced by Zn2+ in a reversible and dose-dependent manner, with an IC50 of 27 microM and a Hill coefficient of 0.4. The inhibition of IAcCho by Zn2+ was competitive and voltage-independent, a behavior incompatible with a channel blockade mechanism. In sharp contrast, in oocytes expressing a receptor mutant, with a threonine-for-leucine 247 substitution (L247Talpha7), subnanomolar concentrations of Zn2+ elicited membrane currents (IZn) that were reversibly inhibited by the nicotinic receptor blockers methyllycaconitine and alpha-bungarotoxin. Cell-attached single-channel recordings showed that Zn2+ opened channels that had a mean open time of 5 ms and a conductance of 48 pS. At millimolar concentrations Zn2+ reduced IAcCho and the block became stronger with cell hyperpolarization. Thus, Zn2+ is a reversible blocker of wild-type alpha7 receptors, but becomes an agonist, as well as an antagonist, following mutation of the highly conserved leucine residue 247 located in the M2 channel domain. We conclude that Zn2+ is a modulator as well as an activator of homomeric nicotinic alpha7 receptors.


Subject(s)
Neurons/metabolism , Point Mutation , Receptors, Nicotinic/drug effects , Receptors, Nicotinic/genetics , Zinc/pharmacology , Acetylcholine/metabolism , Animals , Chickens , DNA, Complementary/genetics , Female , In Vitro Techniques , Ion Channel Gating , Kinetics , Mutagenesis, Site-Directed , Oocytes/drug effects , Oocytes/metabolism , Receptors, Nicotinic/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Xenopus , alpha7 Nicotinic Acetylcholine Receptor
5.
Differentiation ; 32(2): 181-4, 1986.
Article in English | MEDLINE | ID: mdl-3792705

ABSTRACT

The isolation and characterization of a myogenic cell line from C57BL/6J/dydy mice is described. This line (DyA4) maintains the morphological, biochemical and electrophysiological characteristics of the primary cultured cells, at least for 20 passages. The cells actively divide as long as they are subcultured in media supplemented with horse serum and embryo extract. If the cells are not subcultured for a few days, they fuse into multinucleated contracting myotubes, which readily synthesize specific muscle products such as acetylcholinesterase and acetylcholine receptor. This dystrophic cell line expresses in vitro the same altered phenotype that is characteristic of dystrophic muscle cells in primary cultures, namely reduced acetylcholine sensitivity and reduced acetylcholine receptor expression. Because they can be grown in large amounts, and represent a pure muscle cell population which express an altered phenotype in an in vitro aneural avascular environment, DyA4 cells provide a very useful model system for investigating the pathogenesis of murine muscular dystrophy.


Subject(s)
Muscles/pathology , Muscular Dystrophy, Animal/pathology , Acetylcholinesterase/isolation & purification , Acetylcholinesterase/metabolism , Animals , Cell Line , Cells, Cultured , Clone Cells , Mice , Mice, Inbred C57BL , Muscles/cytology , Muscles/enzymology , Muscular Dystrophy, Animal/enzymology , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL